The industry may be on the verge of facing up to potential ‘dry labbing’ issues, which could bring the issue to the forefront and ‘hopefully get this problem fixed’, says ChromaDex’s Frank Jaksch.
Dry labbing is a practice whereby research or analysis is claimed to be done, but in reality the conclusions are guessed at or copied from other sources without actually doing any analysis.
Speaking with NutraIngredients-USA at the recent SupplySide West event in Las Vegas, Jaksch, CEO and co-counder of ChromaDex, said that, while it is difficult to say how widespread this problem is, “I think it’s a problem that goes deeper than people think”.
He added: “There may be more laboratories out there that are pulling this practice than many people think.”
“It’s a matter of having the companies that participate in the industry challenge their laboratories. Send dummy samples, for instance, send a sample that’s not what it’s supposed to be, tell them what you think it is and see what comes back.
“There’s probably going to be something happening soon that may bring this point to the forefront.”